DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slipped 2.34% to $88.50 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,420.10 and Dow Jones Industrial Average falling 0.98% to 51,492.55.
The stock's fall snapped a two-day winning streak.
Abbott Laboratories closed 36.36% short of its 52-week high of $139.06, which the company achieved on June 24th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.42% to $234.20, Pfizer Inc. $(PFE)$ fell 0.46% to $25.92, and Merck & Co. Inc. $(MRK)$ rose 0.23% to $115.44.
Trading volume (12.9 M) eclipsed its 50-day average volume of 12.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 17, 2026 16:36 ET (20:36 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.